Evidence map›Paper›PMID 32548558›Full record

ArticleResearch and practice in thrombosis and haemostasis2020

Quality of anticoagulant therapy and the incidence of in-stent thrombosis after venous stenting.

Pascale Notten, Jorinde H H van Laanen, Pieter Eijgenraam, Mark A F de Wolf, Ralph L M Kurstjens, Hugo Ten Cate, Arina J Ten Cate-Hoek

Open access · goldAbstract read
In one paragraph

Article in Research and practice in thrombosis and haemostasis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Pascale NottenDepartment of Vascular Surgery Maastricht University Medical Centre Maastricht the Netherlands.ORCID https://orcid.org/0000-0002-8270-2000
Jorinde H H van LaanenDepartment of Vascular Surgery Maastricht University Medical Centre Maastricht the Netherlands.
Pieter EijgenraamLaboratory for Clinical Thrombosis and Hemostasis Maastricht University Maastricht the Netherlands.
Mark A F de WolfDepartment of Vascular Surgery Maastricht University Medical Centre Maastricht the Netherlands.
Ralph L M KurstjensDepartment of Vascular Surgery Maastricht University Medical Centre Maastricht the Netherlands.
Hugo Ten CateCARIM School for Cardiovascular Diseases Cardiovascular Research Institute Maastricht Maastricht University Medical Centre Maastricht the Netherlands.
Arina J Ten Cate-HoekCARIM School for Cardiovascular Diseases Cardiovascular Research Institute Maastricht Maastricht University Medical Centre Maastricht the Netherlands.
Maastricht University Medical Centre · NLLeiden University · NLMaastricht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn patients with a venous outflow obstruction following iliofemoral deep vein thrombosis stenting of the venous tract to prevent or alleviate postthrombotic syndrome is applied with increasing frequency. The impact of the quality of anticoagulant therapy with vitamin K antagonists (VKAs) on the development of in-stent thrombosis is currently unknown.

objectivesTo determine the association between the quality of postinterventional VKA treatment and the occurrence of in-stent thrombosis.

methodsSeventy-nine patients with iliofemoral and/or caval venous stent placement for obstruction of the venous outflow were included in this study. All patients received postinterventional VKA. The quality of VKA anticoagulant therapy was expressed as the time within therapeutic range (TTR) calculated using the linear interpolation method and as the proportion of International Normalized Ratio (INR) values < 2.0. In-stent thrombosis was assessed by the use of duplex ultrasound. Survival analysis (Kaplan-Meier curves, Cox regression) was used to analyze the data.

resultsIn-stent thrombosis developed in 16 patients (20.3%). The total population had a mean TTR of 64.0% (±19.0) and a mean proportion of INR values < 2.0 of 11.6% (±12.0). Overall, a TTR < 49.9% was associated with an increased risk of in-stent thrombosis. The multivariable adjusted analysis showed a hazard ratio (HR) of 0.96 (95% confidence interval [CI], 0.92-0.99;

conclusionsWe conclude that the quality of anticoagulant treatment reflected in the TTR following a venous stenting procedure is an important independent determinant for the risk of in-stent thrombosis. The role of anticoagulant treatment for the prevention of in-stent thrombosis following stenting procedures therefore merits further research.

Indexed as

anticoagulantsdeep vein thrombosisInternational Normalized Ratiopostthrombotic syndromestents

Identifiers

PMID32548558
PMCPMC7292674
OpenAlexW3015686529

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.